Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

OTUD5 activates efficient deubiquitination TRIM25. 1 / 1

| 1

➶

eidos

"In the in vitro deubiquitination assay , OTUD5 catalyzed the efficient deubiquitination of TRIM25 , and the TRIM25 deubiquitination required OTUD5 DUB activity , as indicated by the catalytically inactive OTUD5 ( OTUD5 / C224S ) failing to deubiquitinate TRIM25 ( Fig. 3b , c , lane 2 versus lane 5 ) ."

32826889

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...